Bejerano, Gracehell May .

HRN: 25-54-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2024
AMPICILLIN 500MG (VIAL)
07/25/2024
08/01/2024
IV
500mg
Q6
Acute Bacterial Infection
Waiting Final Action 
07/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/27/2024
08/02/2024
IV
110mg
Q8h
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: